| 发明名称 |
Treatment of t-helper cell type 2 mediated immune diseases |
| 摘要 |
Retinoids with retinoid receptor antagonistic activity, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found efficacious in treating T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases. |
| 申请公布号 |
AU1560499(A) |
申请公布日期 |
1999.05.31 |
| 申请号 |
AU19990015604 |
申请日期 |
1998.11.05 |
| 申请人 |
F.HOFFMANN-LA ROCHE AG |
发明人 |
WERNER BOLLAG;MICHAEL KLAUS;PAOLA PANINA-BORDIGNON;FRANCESCO SINIGAGLIA |
| 分类号 |
A61K9/06;A61K9/08;A61K9/107;A61K9/12;A61K9/14;A61K9/20;A61K9/48;A61K9/72;A61K31/166;A61K31/19;A61K31/192;A61K31/195;A61K31/196;A61K31/20;A61K31/201;A61K31/202;A61K31/216;A61K31/35;A61K31/352;A61K31/353;A61K31/38;A61K31/382;A61K31/385;A61K31/407;A61K31/415;A61K31/4162;A61K31/4184;A61K31/44;A61K31/4439;A61K31/55;A61K31/551;A61K31/5513;A61K45/00;A61P11/00;A61P11/02;A61P11/06;A61P17/00;A61P27/16;A61P29/00;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07C57/42;C07C57/48;C07D235/02;C07D243/38;C07D311/58;C07D335/06;C07D339/02;C07D401/06;C07D495/04 |
主分类号 |
A61K9/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
